“Breast Cancer Subtypes Based on ER, PR and HER2/neu Expression and Its Clinico-pathological Correlation”, J Curr Adv Med Res, vol. 7, no. 1, pp. 30–35, Apr. 2020, doi: 10.3329/jcamr.v7i1.46427.